Penn Medicine Abramson Cancer Center


 

2020 ASCO Update on Lymphomas: Should Pembro Be New SoC in R/R cHL? Is Axicabtagene Ciloleucel Effective and Durable in R/R Indolent Non-Hodgkin Lymphoma?

241 views
July 22, 2020
0 Comments
Login to view comments. Click here to Login
2020 Updates in Oncology